SpineGuard S.A.
ALSGD.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | 0.24 | 0.03 | -0.07 |
| FCF Yield | -11.85% | -5.07% | -19.77% | -7.93% |
| EV / EBITDA | -10.96 | -6.76 | -7.27 | -4.11 |
| Quality | ||||
| ROIC | -11.17% | -28.20% | -22.04% | -22.23% |
| Gross Margin | 78.48% | 76.48% | 79.48% | 77.49% |
| Cash Conversion Ratio | 0.60 | 0.34 | 1.15 | 0.25 |
| Growth | ||||
| Revenue 3-Year CAGR | -5.44% | -8.46% | -9.08% | -11.71% |
| Free Cash Flow Growth | -29.40% | 71.46% | -217.77% | 83.20% |
| Safety | ||||
| Net Debt / EBITDA | -2.32 | -0.98 | -1.14 | -0.12 |
| Interest Coverage | -2.26 | -14.06 | -9.80 | -10.41 |
| Efficiency | ||||
| Inventory Turnover | 0.60 | 0.60 | 0.51 | 0.49 |
| Cash Conversion Cycle | -60.66 | -30.68 | 12.27 | -18.00 |